Skip to main content

Advertisement

Log in

Changing presentation of acromegaly in half a century: a single-center experience

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Objective

Investigate the changes in the characteristics of presentation, in patients with acromegaly over a period of approximately half a century.

Methods

The medical records of patients diagnosed with acromegaly between 1980 and 2023 were retrospectively reviewed. The collected data were examined to assess any changes observed over the years and a comparison was made between the characteristics of patients diagnosed in the last decade and those diagnosed in previous years.

Results

A total of 570 patients were included in the study, 210 (37%) patients were diagnosed in the last decade. Patients diagnosed before 2014 had longer symptom duration before diagnosis, advanced age, larger pituitary adenomas, higher incidence of cavernous sinus invasion, and higher GH and IGF-1 levels than those diagnosed last decade (p < 0.05, for all). Furthermore, the patients diagnosed before 2014 had a lower rate of surgical remission (p < 0.001), and a higher prevalence of comorbidities such as diabetes, hypertension, colon polyps, and thyroid cancer at the time of diagnosis (p < 0.05, for all).

Conclusion

There may be a trend for earlier detection of patients with acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

All data obtained or analyzed as part of this study are included in this article [and/or] its tables. The data archive can be made available on request. Further requests can be directed to the corresponding author.

References

  1. Melmed S (2006) Medical progress: acromegaly [published correction appears in N Engl J Med. 2007;356(8):879]. N Engl J Med 355(24):2558–2573. https://doi.org/10.1056/NEJMra062453

    Article  CAS  PubMed  Google Scholar 

  2. Katznelson L, Laws ER Jr, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951. https://doi.org/10.1210/jc.2014-2700

    Article  CAS  PubMed  Google Scholar 

  3. Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72(2):203–208. https://doi.org/10.1111/j.1365-2265.2009.03626.x

    Article  PubMed  Google Scholar 

  4. Molitch ME (1992) Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 21(3):597–614

    Article  CAS  PubMed  Google Scholar 

  5. Nabarro JD (1987) Acromegaly. Clin Endocrinol (Oxf) 26(4):481–512. https://doi.org/10.1111/j.1365-2265.1987.tb00805.x

    Article  CAS  PubMed  Google Scholar 

  6. Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2(1):29–41. https://doi.org/10.1023/a:1009965803750

    Article  CAS  PubMed  Google Scholar 

  7. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41(1):95–102. https://doi.org/10.1111/j.1365-2265.1994.tb03789.x

    Article  CAS  PubMed  Google Scholar 

  8. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152. https://doi.org/10.1210/er.2002-0022

    Article  CAS  PubMed  Google Scholar 

  9. Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89(2):667–674. https://doi.org/10.1210/jc.2003-031199

    Article  CAS  PubMed  Google Scholar 

  10. Clemmons DR (2011) Clinical laboratory indices in the treatment of acromegaly. Clin Chim Acta 412(5–6):403–409. https://doi.org/10.1016/j.cca.2010.11.008

    Article  CAS  PubMed  Google Scholar 

  11. Clemmons DR (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 57(4):555–559. https://doi.org/10.1373/clinchem.2010.150631

    Article  CAS  PubMed  Google Scholar 

  12. Freda PU, Beckers AM, Katznelson L et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894–904. https://doi.org/10.1210/jc.2010-1048

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Keskin FE, Yetkin DO, Ozkaya HM et al (2015) The problem of unrecognized acromegaly: surgeries patients undergo before diagnosis of acromegaly. J Endocrinol Invest 38(6):695–700. https://doi.org/10.1007/s40618-015-0245-3

    Article  CAS  PubMed  Google Scholar 

  14. Melmed S, Acromegaly (1990) N Engl J Med 322(14):966–977. https://doi.org/10.1056/NEJM199004053221405

    Article  CAS  PubMed  Google Scholar 

  15. Giustina A, Barkan A, Beckers A et al (2020) A Consensus on the diagnosis and treatment of Acromegaly Comorbidities: an update. J Clin Endocrinol Metab 105(4):dgz096. https://doi.org/10.1210/clinem/dgz096

    Article  PubMed  Google Scholar 

  16. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610–618. https://doi.org/10.1227/00006123-199310000-00008

    Article  CAS  PubMed  Google Scholar 

  17. Boguszewski CL (2020) Acromegaly: ‘You must know it to think of it’. Eur J Endocrinol 183(1):C1–C4. https://doi.org/10.1530/EJE-20-0281

    Article  CAS  PubMed  Google Scholar 

  18. Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20(1):4–9. https://doi.org/10.1007/s11102-016-0754-x

    Article  PubMed  Google Scholar 

  19. Dal J, Feldt-Rasmussen U, Andersen M et al (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):181–190. https://doi.org/10.1530/EJE-16-0117

    Article  CAS  PubMed  Google Scholar 

  20. Burton T, Le Nestour E, Neary M, Ludlam WH (2016) Incidence and prevalence of acromegaly in a large US health plan database. Pituitary 19(3):262–267. https://doi.org/10.1007/s11102-015-0701-2

    Article  PubMed  PubMed Central  Google Scholar 

  21. Turkish Society of Endocrinology and Metabolism (2023) Current number of member physicians. https://www.temd.org.tr/. Accessed 5 Jul 2023

  22. Johns Hopkins University (2021) COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Accessed 5 Jul 2023

  23. Republic of Turkey Ministry of Health (2020) Republic of Turkey Ministry of Health Corona Table. https://covid19.saglik.gov.tr/. Accessed 5 Jul 2023

  24. Durcan E, Turan S, Sahin S et al (2021) Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease. Pituitary 24(4):589–599. https://doi.org/10.1007/s11102-021-01136-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zarool-Hassan R, Conaglen HM, Conaglen JV, Elston MS (2016) Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners. J Prim Health Care 8(2):157–163. https://doi.org/10.1071/HC15033

    Article  PubMed  Google Scholar 

  26. Davidoff LM (1926) Studies in acromegaly. III. The anamnesis and symptomatology in one hundred cases. Endocrinology 10(5):461–483. https://doi.org/10.1210/endo-10-5-461

    Article  Google Scholar 

  27. Rivoal O, Brézin AP, Feldman-Billard S, Luton JP (2000) Goldmann perimetry in acromegaly: a survey of 307 cases from 1951 through 1996. Ophthalmology 107(5):991–997. https://doi.org/10.1016/s0161-6420(00)00060-9

    Article  CAS  PubMed  Google Scholar 

  28. Mateos CF, García-Uria M, Morante TL, García-Uria J (2017) Erratum to: Acromegaly: surgical results in 548 patients. Pituitary 20(5):529–530. https://doi.org/10.1007/s11102-017-0816-8

    Article  PubMed  Google Scholar 

  29. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL (2002) Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 87(8):3537–3542. https://doi.org/10.1210/jcem.87.8.8658

    Article  CAS  PubMed  Google Scholar 

  30. Butz LB, Sullivan SE, Chandler WF, Barkan AL (2016) Micromegaly”: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era. Pituitary 19(6):547–551. https://doi.org/10.1007/s11102-016-0735-0

    Article  CAS  PubMed  Google Scholar 

  31. Freda PU, Wardlaw SL, Post KD (1998) Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89(3):353–358. https://doi.org/10.3171/jns.1998.89.3.0353

    Article  CAS  PubMed  Google Scholar 

  32. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86(9):4072–4077. https://doi.org/10.1210/jcem.86.9.7819

    Article  CAS  PubMed  Google Scholar 

  33. Haliloglu O, Kuruoglu E, Ozkaya HM et al (2016) Multidisciplinary Approach for Acromegaly: a single Tertiary Center’s experience. World Neurosurg 88:270–276. https://doi.org/10.1016/j.wneu.2015.12.092

    Article  PubMed  Google Scholar 

  34. Aydin S, Ozoner B, Sahin S et al (2020) A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly. Clin Neurol Neurosurg 198:106201. https://doi.org/10.1016/j.clineuro.2020.106201

    Article  PubMed  Google Scholar 

Download references

Funding

This study received no specific grants from public, commercial, or nonprofit entities.

Author information

Authors and Affiliations

Authors

Contributions

All authors made substantial contributions to the conception and design and/or data collection and/or analysis and interpretation of the data; participated in writing the article or critically revised it for important intellectual content; gave final approval for the version to be submitted.

Corresponding author

Correspondence to Pinar Kadioglu.

Ethics declarations

Competing interests

The authors have no relevant financial or non-financial and declare no conflict of interest.

Ethical Statement

The study conformed to the ethical principles for medical research with human participants as described in the Declaration of Helsinki of the World Medical Association. The Ethics Committee of Istanbul-University-Cerrahpaşa approved the study (approval number: 701566).

Informed Consent

Signed informed consent was obtained from all study participants.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demir, A.N., Sulu, C., Kara, Z. et al. Changing presentation of acromegaly in half a century: a single-center experience. Pituitary 26, 573–582 (2023). https://doi.org/10.1007/s11102-023-01344-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-023-01344-1

Keywords

Navigation